Sign In   |   Register
European Lipoprotein Club (ELC)

The ELC's Mission

The European Lipoprotein Club (ELC) was established in 1977 in order "to promote active participation, collaboration and exchange of ideas concerning basic and clinical research on the structure, function and metabolism of lipoproteins in health and disease".

The ELC today

The ELC currently comprises over 500 scientists from more than 20 countries in Europe and abroad, and the number grows every year. The ELC is thus a worldwide network of basic scientists and clinicians involved in lipoprotein research. The network is strengthened and expanded by contacts established at the ELC meetings, and fostered by the exchange of ideas, clinical material, techniques and young visiting investigators. This year the 42nd edition of the ELC meeting will take place in Tutzing, 09-12 September, 2019. 

The ELC organisation and governance

The European Lipoprotein Club is based on individual membership. Scientists and students
residing in Europe or neighbouring countries, who are engaged in activities in line with the
objectives stipulated in Article 2 in the statutes of ELC, may apply to attend the scientific meeting to present their work. Every participant at the annual meeting becomes a member of the Club.

ELC's governing body is the Organising Committee. Membership of the Organising Committee is based on ballot elections held at the annual meeting. Every participant in the scientific meeting, including committee members have one vote at the ballot. Members will be asked to nominate candidates for the Organizing Committee. Such nominations shall be sent to the EAS/ELC office at least 3 months prior to the election which will take place at the annual meeting of the ELC. The nominations will be reviewed by the Organizing Committee, who will select from them the candidates to stand for election, based on (a) the nominee’s qualifications and suitability for the position, (b) geographical spread of candidates and existing OC members and (c) gender balance.

ELC is run according to the ELC statutes, which were approved at the General Assembly of the European Lipoprotein Club's 39th Scientific Meeting, Tutzing, Germany, September 2016.

ELC organising committe :: ELC Statutes

ELC background

Scientific meeting in Tutzing

The ELC organises one scientific meeting every year (usually in the second week of September), with particular emphasis on an active participation and in-depth discussion in an informal atmosphere. Since 1980 the meetings have been held at the Evangelische Akademie in Tutzing, Germany. An organising committee, currently of 12 members, representing as many different European countries as possible, arranges the meetings. These representatives are elected by the members and serve for 5 years. One representative acts as the chairman of the Club and has the major responsibility for the organisation of the meeting. From 1980 to 2011, the local organisation of the meeting has been in the hands of the late Dr. Joachim Ziegenhorn and his colleagues from Boehringer Mannheim/Roche. Since 2012 the local organisation has been undertaken by Dr. Joachim Siedel.

The new chairman from 2018 is Professor Patrick Rensen, Leiden, The Netherlands. Professor Dagmar Kratky from Graz, Austria, acts as treasurer from 2017. Three to five topics, selected by the organising committee, are discussed at each meeting, in five working sessions spread over four days, starting with a Keynote Lecture by an invited speaker on Monday evening. Anyone interested and involved in research in the lipoprotein field is invited to submit an abstract for the meeting. Participants are selected on the relevance and scientific merit of their abstracts, and approximately 30 of those attending the meeting are chosen to give an oral presentation. Because of the size of the lecture hall, and in order to maintain an atmosphere conducive to active discussion, participants are limited to 110.


For many years, the ELC was generously supported by Boehringer Mannheim, and thereafter by F. Hoffmann-LaRoche. During recent years, sponsorship has been received from Akcea Therapeutics, Amgen, AstraZeneca, Atherosclerosis journal, Boehringer Ingelheim, Clinical Science, COST - European Cooperation in Science and Technology, DFG/German Research Foundation, Genfit, GlaxoSmithKline, Lipidon, Lipigon Pharmaceuticals, Mabtech, Merck Sharpe and Dohme, Nightingale Health, Nebion, Novo Nordisk, Numares Health, PolyQuant, Sable systems, Sciex and TSE systems. Since 2013 a major sponsor of the ELC has been the European Atherosclerosis Society, allowing to sustain the high quality of the meetings.

Membership Software Powered by YourMembership  ::  Legal